IMBRIANO, Carol
 Distribuzione geografica
Continente #
NA - Nord America 11.362
AS - Asia 6.096
EU - Europa 5.650
SA - Sud America 923
AF - Africa 145
OC - Oceania 80
Continente sconosciuto - Info sul continente non disponibili 4
Totale 24.260
Nazione #
US - Stati Uniti d'America 11.140
SG - Singapore 2.002
IT - Italia 1.828
CN - Cina 1.587
GB - Regno Unito 1.257
HK - Hong Kong 764
BR - Brasile 704
VN - Vietnam 697
SE - Svezia 652
DE - Germania 391
FR - Francia 284
FI - Finlandia 239
RU - Federazione Russa 236
KR - Corea 183
UA - Ucraina 175
IN - India 165
ID - Indonesia 121
TR - Turchia 113
JP - Giappone 95
MX - Messico 93
CA - Canada 86
AR - Argentina 84
NL - Olanda 80
AU - Australia 79
BD - Bangladesh 79
BG - Bulgaria 70
ES - Italia 69
CZ - Repubblica Ceca 64
BE - Belgio 50
ZA - Sudafrica 50
PL - Polonia 43
IE - Irlanda 42
IQ - Iraq 41
LT - Lituania 40
EC - Ecuador 33
AE - Emirati Arabi Uniti 27
AT - Austria 27
CO - Colombia 26
UZ - Uzbekistan 25
PK - Pakistan 24
EG - Egitto 22
MA - Marocco 22
MY - Malesia 22
CH - Svizzera 20
CL - Cile 19
SA - Arabia Saudita 19
PH - Filippine 17
VE - Venezuela 17
TW - Taiwan 15
PY - Paraguay 14
UY - Uruguay 14
TH - Thailandia 11
TN - Tunisia 11
DZ - Algeria 10
IL - Israele 10
IR - Iran 10
NP - Nepal 10
PT - Portogallo 10
ET - Etiopia 9
JO - Giordania 9
KE - Kenya 9
LB - Libano 9
PE - Perù 9
AL - Albania 8
CR - Costa Rica 8
RS - Serbia 8
GR - Grecia 7
JM - Giamaica 6
RO - Romania 6
SI - Slovenia 6
AZ - Azerbaigian 5
BY - Bielorussia 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
NI - Nicaragua 5
SN - Senegal 5
EE - Estonia 4
GE - Georgia 4
HR - Croazia 4
HU - Ungheria 4
KZ - Kazakistan 4
LV - Lettonia 4
PA - Panama 4
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
BO - Bolivia 3
CI - Costa d'Avorio 3
EU - Europa 3
KG - Kirghizistan 3
KW - Kuwait 3
LK - Sri Lanka 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
BZ - Belize 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MD - Moldavia 2
Totale 24.235
Città #
Ashburn 1.256
Singapore 1.226
Santa Clara 1.060
Fairfield 1.059
Southend 758
Hong Kong 738
Woodbridge 658
Chandler 594
Hefei 512
San Jose 480
Houston 445
Seattle 390
Ann Arbor 384
Modena 363
Cambridge 355
Wilmington 344
Nyköping 303
Jacksonville 296
Beijing 279
Dearborn 256
London 224
Los Angeles 222
Ho Chi Minh City 214
New York 178
Council Bluffs 174
Milan 172
Hanoi 171
Bologna 166
The Dalles 165
Seoul 164
Helsinki 138
Chicago 132
San Diego 101
Jakarta 95
Reggio Emilia 91
Munich 81
Lauterbourg 79
Moscow 74
Shanghai 73
Tokyo 72
Princeton 69
São Paulo 68
Sofia 67
Buffalo 59
Eugene 59
Parma 59
Izmir 53
Bremen 51
Brno 45
Dong Ket 45
Orem 45
Dallas 43
Fremont 43
Salt Lake City 43
Brussels 41
Mexico City 41
Phoenix 40
Turku 38
Da Nang 37
Frankfurt am Main 36
Warsaw 35
Columbus 34
Dublin 34
Montreal 32
Poplar 32
Rome 32
Denver 31
Durham 29
Johannesburg 29
Redwood City 29
Chennai 28
Boardman 27
Brooklyn 27
Formigine 27
Mumbai 26
Stockholm 26
Atlanta 25
Kent 25
Paris 25
Falls Church 24
Rio de Janeiro 24
Tampa 24
Tashkent 24
Amsterdam 23
Des Moines 23
Elk Grove Village 23
Haiphong 23
Toronto 23
Baghdad 22
Turin 22
Norwalk 21
Belo Horizonte 20
Guangzhou 19
Medesano 19
Nuremberg 19
Brasília 17
Lappeenranta 16
Manchester 16
Naples 16
Perugia 15
Totale 16.510
Nome #
Dynamic Phosphorylation of the Myocyte Enhancer Factor 2Cα1 Splice Variant Promotes Skeletal Muscle Regeneration and Hypertrophy 431
Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters 424
An autoregulatory loop controls the expression of the transcription factor NF-Y 418
NF-YA splice variants have different roles on muscle differentiation 406
Potent Anti-Cancer Properties of Phthalimide-Based Curcumin Derivatives on Prostate Tumor Cells 406
Newly synthesized curcumin derivatives: crosstalk between chemico-physical properties and biological activity. 390
NF-Y splice variants differentially affect skeletal myogenesis 385
A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response 381
Curcumin derivatives: molecular basis of their anti-cancer activity. 381
Curcumin derivatives and Aβ-fibrillar aggregates: An interactions’ study for diagnostic/therapeutic purposes in neurodegenerative diseases 376
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 376
Direct non transcriptional role of NF-Y in DNA replication 370
Transcriptionally regulated and non-toxic delivery of the hyperactive Sleeping Beauty Transposase 361
Transcriptionally regulated and nontoxic delivery of the hyperactive Sleeping Beauty Transposase 359
Direct p53 transcriptional repression: In vivo analysis of CCAAT-containing G2/M promoters 357
NF-Y recruitment of TFIID, multiple interactions with histone fold TAF(II)s 351
Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells 349
The NF-Y/p53 liaison: Well beyond repression. 349
bis-Dehydroxy-Curcumin Triggers Mitochondrial-Associated Cell Death in Human Colon Cancer Cells through ER-Stress Induced Autophagy. 348
NF-Y activates genes of metabolic pathways altered in cancer cells 347
Phosphorylation and alternative splicing of MEF2C, a dual switch function in muscle regeneration 345
Alternative splicing of transcription factors genes in muscle physiology and pathology 340
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 333
NF-Y co-associates with FOS at promoters, enhancers, repetitive elements, and inactive chromatin regions, and is stereo-positioned with growth-controlling transcription factors. 325
Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2 324
Dissection of the NF-Y transcriptional activation potential 324
HSP-CBF is an NF-Y-dependent coactivator of the heat shock promoters CCAAT boxes 320
NF-Y loss triggers p53 stabilization and apoptosis in HPV18-positive cells by affecting E6 transcription 320
Structure-Based Design of Potent Aromatase Inhibitors by High-Throughput Docking 317
Ternary complex formation between MADS-box transcription factors and the histone fold protein NF-YB 315
Gain-of-function p53 mutants have widespread genomic locations partially overlapping with p63 315
An acetylation-mono-ubiquitination switch on lysine 120 of H2B 309
The interplay between NF-Y, AR and lipid metabolism regulates tumor aggressiveness in prostate cancer. 307
Alternative splicing of the transcription factor NF-Y promotes cell migration and invasion in colon cancer 307
Dysregulation of NF–Y splicing drives metabolic rewiring and aggressiveness in colon cancer 306
New curcumin-derived ligands and their affinity towards Ga3+, Fe3+and Cu2+: Spectroscopic studies on complex formation and stability in solution 306
The 1,10-phenanthroline ligand enhances the antiproliferative activity of dna-intercalating thiourea-pd(Ii) and-pt(ii) complexes against cisplatin-sensitive and-resistant human ovarian cancer cell lines 298
Specific inhibition of NF-Y subunits triggers different cell proliferation defects. 296
DNA damage promotes histone deacetylase 4 nuclear localization and repression of G2/M promoters via p53 C-terminal lysines 294
Switch of NF-YA splice variants in prostate cancer development and progression 292
Cloning and characterization of the histone-fold proteins YBL1 and YCL1 285
BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting 284
Probing solute–solvent hydrogen bonding with fluorescent water-soluble curcuminoids 283
Alterations in NF-Y splicing enable the metabolic plasticity of colon cancer cells and foster dynamic interactions within the tumor niche 280
A non transcriptional role for NF-Y in DNA replication 280
A specific role for the splice variants of the transcription factor NF-Y in modulating the transcriptional activity of the myogenic program 278
Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads 270
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 267
NF-YC complexity is generated by dual promoters and alternative splicing 266
Role of the CCAAT-transcription factor NF-Y and its splice variants in myogenic differentiation and muscle regeneration 259
Scouting Sigma Receptor Ligands As New Tools For The Treatment Of Neurodegenerative Diseases And Cancer 259
Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates 255
Dynamic recruitment of transcription factors and epigenetic changes on the ER stress response gene promoters 253
Development of new metal-chelating multi target drus derived from Curcumin 252
Direct non transcriptional role of the CCAAT-factor NF-Y in DNA replication 249
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer 246
The NF-YA Splicing Signature Controls Aggressiveness of Colon Cancer by Regulating Cell Metabolism and Different Types of Cell Migration 245
Role of the transcriprion factor NF-Y in cell cycle regulation 241
Development of new therapeutic Metal(III)-chelating agents derived from Curcumin 235
Monitoring DNA Hybridization with Organic Electrochemical Transistors Functionalized with Polydopamine 233
The NF-YA splicing signature controls aggressiveness of colon cancer by regulating different modes of cell migration and cell metabolism. 222
Bridging pyrimidine hemicurcumin and Cisplatin: Synthesis, coordination chemistry, and in vitro activity assessment of a novel Pt(II) complex 221
DNA damage promotes HDAC4 nuclear localization and G2/M promoters repression via p53 C-terminal lysisnes 218
Understanding the molecular mechanisms of Curcumin derivatives chemotherapic activity 217
Development of new metal-based phyto-radiopharmaceuticals: diagnostic agents derived from Cur(e)cumin 216
The transcription factor NF-Y is required for satellite stem cell proliferation and skeletal muscle tissue repair 214
The transcription factor NF-Y participates to stem cell fate decision and regeneration in adult skeletal muscle 214
NF-Y LOSS REACTIVATES p53 AND TRIGGERS p53-DEPENDENT APOPTOSIS IN HPV-POSITIVE HUMAN CERVICAL CARCINOMA CELLS 213
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 213
Development of Stable Amino-Pyrimidine–Curcumin Analogs: Synthesis, Equilibria in Solution, and Potential Anti-Proliferative Activity 212
Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells 211
Expression of the CCAAT-binding factor NF-Y in Caenorhabditis elegans 203
Investigation of transcription factor–DNA binding with electrolyte-gated organic transistors 194
The NF–Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer 189
In situ immunofluorescent staining of autophagy in muscle stem cells 189
Histone deacetylase functions and therapeutic implications for adult skeletal muscle metabolism 185
Deciphering the transcriptional network of NF-Y in prostate cancer development and progression 184
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 182
Cell cycle regulation of NF-YC nuclear localization 181
Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives 169
Histone Marks-Dependent Effect on Alternative Splicing: New Perspectives for Targeted Splicing Modulation in Cancer? 149
Searching for Novel HDAC6/Hsp90 Dual Inhibitors with Anti-Prostate Cancer Activity: In Silico Screening and In Vitro Evaluation 147
The transcription factor NF-Y participates in prostate cancer progression and response to androgen-deprivation therapy 145
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 134
The transcription factor NF-Y is required for satellite stem cell myogenic progression and skeletal muscle tissue repair 134
Cross-talk between NF-Y transcription factor and m6A epitanscriptomic regulators in colon cancer: molecular characterization and clinical relevance. 132
Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function 119
The NF–Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer 112
The role(s) of NF-Y in development and differentiation 93
Correction: Investigation of transcription factor-DNA binding with electrolyte-gated organic transistors (J. Mater. Chem. C (2024) 12 (7596–7604) DOI: 10.1039/D4TC00260A) 73
Targeting monocarboxylate transporter 1 with a copper-chelating coumarin-based bioconjugate: Synthesis and characterization 65
Metabolic reprogramming controlled by NF-YA alternative splicing creates therapeutic opportunities in colorectal cancer 11
MXene‐Based Conductive Micropatterned Composites Promote Myogenic Differentiation of Muscle Cells 8
null 4
Totale 24.451
Categoria #
all - tutte 83.041
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.041


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021367 0 0 0 0 0 0 0 0 0 0 206 161
2021/20221.672 78 147 175 113 75 111 101 72 202 135 297 166
2022/20231.960 199 260 125 173 202 246 56 182 204 52 153 108
2023/20241.647 60 75 101 151 295 133 244 135 28 65 135 225
2024/20254.889 146 54 203 323 880 759 434 297 469 271 500 553
2025/20267.921 610 385 684 1.068 1.365 589 1.006 391 855 860 108 0
Totale 24.451